SCHEMBL27872502

SCHEMBL27872502

CCC(=O)[C@]1(N)CCCN1

nearest known ligand 0.31

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 3/20 0.31
SLC6A2 P23975 3/20 0.31
SLC6A4 P31645 3/20 0.31
SLC6A3 Q01959 3/20 0.31
KCNH2 Q12809 1/20 0.31
ARG1 P05089 1/20 0.30
ARG2 P78540 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22793161 0.77
SCHEMBL3407152 0.74
SCHEMBL13762916 0.74
SCHEMBL3103050 0.74
SCHEMBL16585834 0.74
SCHEMBL14665033 0.73 CYP2D6 (0.32) CYP2D6SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL28495057 0.72
SCHEMBL19718510 0.69 ARG1 (0.30) ARG1
SCHEMBL3548986 0.68 CRBN (0.33)
SCHEMBL2004047 0.68 ARG1 (0.33) ARG1ARG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102427726-B fused ring inhibitors of hepatitis c PRESIDIO PHARMACEUTICALS, INC. (US) 2014-10-08 CN disclosed
CN-102427726-A Fused ring inhibitors of hepatitis c PRESIDIO PHARMACEUTICALS INC 2012-04-25 CN disclosed